The U.S. remote patient monitoring system market size is anticipated to reach USD 6.3 billion by 2030, growing at a CAGR of 18.4% during the forecast period, according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases, such as diabetes, hypertension, and heart diseases has led to a higher demand for remote patient monitoring systems. These systems help manage chronic conditions more effectively, reducing hospitalizations and improving patient outcomes.
The U.S. healthcare system is moving towards value-based care, which emphasizes better patient outcomes and cost efficiency. Remote patient monitoring systems align with this shift, as they help reduce healthcare costs and improve patient outcomes. Remote patient monitoring systems enable early detection of health issues, allowing for timely interventions and better preventive care. This has led to increased adoption of these systems in the U.S. market.
According to the Centers for Disease Control and Prevention (CDC), in 2021, hypertension was a primary or one of the major contributing causes of the 691,095 deaths in the U.S. The treatment of chronic diseases such as diabetes and hypertension require routine testing and monitoring, due to which, these remote patient monitoring devices are needed. The incensing cases of diabetes in the U.S., in turn, drives the demand of these devices.
Request a free sample copy or view report summary: U.S. Remote Patient Monitoring System Market Report
Specialized monitors dominated the product segment with more than 80.0% share in 2023 owing to their specific parameters with greater accuracy compared to the general devices
The vital sign monitors product segment is expected to grow at the fastest CAGR over the forecast period
The diabetes application segment held the largest market share in 2023. Diabetic patients often need to monitor their blood glucose levels multiple times a day to maintain optimal control
The sinus infections application segment accounted for the largest market share in 2023, owing to their complications and significant role played by remote patient monitoring systems in diagnosing and preventing further infection
Grand View Research has segmented the U.S. remote patient monitoring system market based on product, infection, application, and end-use:
U.S. Remote Patient Monitoring System Product Outlook (Revenue, USD Million, 2018 - 2030)
Vital Sign Monitors
Blood Pressure Monitors
Pulse Oximeters
Heart Rate Monitor (ECG)
Temperature Monitor
Respiratory Rate Monitor
Capnographs
Spirometers
Brain Monitoring (EEG)
Specialized Monitors
Anesthesia Monitors
Blood Glucose Monitors
Cardiac Rhythm Monitor
Respiratory Monitor
Fetal Heart Monitors
Prothrombin Monitors
Multi Parameter Monitors (MPM)
Others (Ventilators, Infusion Pumps and others)
U.S. Remote Patient Monitoring System Application Outlook (Revenue, USD Million, 2018 - 2030)
Cancer
Cardiovascular Diseases
Diabetes
Sleep Disorder
Weight Management and Fitness Monitoring
Bronchitis
Infections
Virus
Dehydration
Hypertension
U.S. Remote Patient Monitoring System End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital-based Patients
Ambulatory Patients
Home Healthcare
U.S. Remote Patient Monitoring System Infection Outlook (Revenue, USD Million, 2018 - 2030)
Eye Infections
Sinus Infections
Strep Throat
List of Key Players in the U.S. Remote Patient Monitoring System Market
Welch Allyn
Smiths Medical
Abbott
Boston Scientific Corporation
Dräger Medical
GE Healthcare
Honeywell
Johnson & Johnson
LifeWatch
Medtronic
Masimo
Vitls, Inc
CareValidate
Biotronik
American Telecare
"The quality of research they have done for us has been excellent..."